News
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...
Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later this ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results